Zydus Lifesciences Limited Trastuzumab Export Data — India (DGFT 2022–2026)

Name: Zydus Lifesciences Limited Trastuzumab Export Records India — #3 Exporter, 68 Shipments, $3.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Trastuzumab

India Pharmaceutical Trade Intelligence

$77.2M179 Suppliers108 CountriesHS 30049099

ExportsIndia → NETHERLANDS37.9%India → TURKEY13.1%

ImportsGERMANY → India$24.8B SWITZERLAND → India$448.1M

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN IRELAND

Zydus Lifesciences Limited — Trastuzumab Exporter #3 | $3.4M Trade Value | TransData Nexus | TransData Nexus

Zydus Lifesciences Limited — Trastuzumab Exporter Profile

Indian Pharmaceutical Exporter · #3 for Trastuzumab · $3.4M export value · DGFT Verified

Zydus Lifesciences Limited is the #3 Indian exporter of Trastuzumab with $3.4M in export value and 68 verified shipments. Zydus Lifesciences Limited holds a 4.4% market share in Trastuzumab exports across 8 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.

Zydus Lifesciences Limited — Trastuzumab Export Profile: Buyers & Destinations

Zydus Lifesciences Limited Trastuzumab export treemap — buyers and destination countries | TransData Nexus

Where Does Zydus Lifesciences Limited Export Trastuzumab?

Country	Value	Shipments	Share
KENYA	$210.2K	5	18.2%
CAMBODIA	$186.0K	4	16.1%
BOLIVIA	$174.3K	6	15.1%
INDONESIA	$150.0K	3	13.0%
MEXICO	$150.0K	3

Who Are the Top Buyers of Trastuzumab from Zydus Lifesciences Limited?

Buyer	Country	Value	Orders
ZYDUS PHARMACEUTICALS M?XICO S.A. D	MEXICO	$150.0K	3
FARMEDICAL S.R.L.	BOLIVIA	$147.5K	5
MEGA LIFESCIENCES PTY LTD	CAMBODIA	$140.2K	3
RIPPLE PHARMACEUTICALS	KENYA	$110.2K	3
RIPPLE PHARMACEUTICALS LTD	KENYA	$100.0K	2
KIMIA FARMA TBK, PT	INDONESIA	$100.0K	2
D. K. M. PHARMACEUTICALS PVT. LTD.	NEPAL	$96.4K	29
KIMIA FARMA TBK. PT	INDONESIA	$50.0K	1
MYIT MAHAR TRADING CO LIMITED	MYANMAR	$50.0K	1
MYIT MAHAR TRADING CO.LIMITED	MYANMAR	$50.0K	1

Zydus Lifesciences Limited supplies Trastuzumab to 15 buyers globally. The largest buyer is ZYDUS PHARMACEUTICALS M?XICO S.A. D (MEXICO), followed by FARMEDICAL S.R.L. (BOLIVIA) and MEGA LIFESCIENCES PTY LTD (CAMBODIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Trastuzumab Formulations Does Zydus Lifesciences Limited Export?

Product Description / Formulation	Value	Shipments
Mamitra(Trastu Inj440mg)withDil.VialSLMX(TRASTUZUMAB LYOPHILIZED POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION)	$150.0K	3
VIVITRA (TRASTUZUMAB 440MG) (TRASTUZUMAB	$142.5K	3
TRASTUZUMAB 440MG INJ 1 VIAL (TRASTUZUMA	$97.3K	3
VIVITRA 440MG INJECTION 1 VIAL (TRASTUZUMAB 440MG) (1002X1X1VIAL)VLS	$50.0K	1
VIVITRA 440 MG INJECTION 1 VIAL (TRASTUZUMAB)(1X1 VIAL)VLS	$50.0K	1
VIVITRA 440 MG INJECTION 1 VIAL (TRASTUZUMAB) QTY. 457.000-AS PER INVOICENOS	$50.0K	1
VIVITRA (TRASTUZUMAB 440MG)(TRASTUZUMAB(1X1 VIAL)	$50.0K	1
VIVITRA 440MG INJECTION 1 VIAL (TRASTUZUMAB 440MG) (500X1X1VIAL)	$50.0K	1
VIVITRA 440MG INJECTION 1 VIAL (TRASTUZUMAB 440MG) (1000X1X1VIAL)	$50.0K	1
VIVITRA 440MG INJECTION 1 VIAL (TRASTUZUMAB) (273X1X1VIAL)	$50.0K	1

Zydus Lifesciences Limited exports 47 distinct Trastuzumab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Mamitra(Trastu Inj440mg)withDil.VialSLMX(TRASTUZUMAB LYOPHIL with 3 shipments worth $150.0K.

How Does Zydus Lifesciences Limited Compare to Nearest Trastuzumab Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MYLAN LABORATORIES LIMITED	$25.1M	503	7	$50.0K
4	RELIANCE LIFE SCIENCES PRIVATE LIMITED	$3.8M	75	15	$50.0K
3	ZYDUS LIFESCIENCES LIMITED ★	$3.4M	68	8	$50.0K
2	BIOCON BIOLOGICS INDIA LIMITED	$1.9M	39	17	$50.0K
9	NU HOSPITALS PRIVATE LIMITED	$673.7K	62	1	$10.9K

Zydus Lifesciences Limited ranks #3 among 179 Indian Trastuzumab exporters. Average shipment value of $50.0K compared to the market average of $208.0K. The closest competitors by value are MYLAN LABORATORIES LIMITED and RELIANCE LIFE SCIENCES PRIVATE LIMITED.

Which Indian Ports Ship Trastuzumab Exports?

Port	Shipments	% Share
SAHAR AIR	379	20.1%
SAHAR AIR CARGO ACC (INBOM4)	319	17.0%
BANGALORE AIR	254	13.5%
BANGALORE ACC (INBLR4)	186	9.9%
Bombay Air	99	5.3%
DELHI AIR	74	3.9%
AHEMDABAD AIR ACC (INAMD4)	62	3.3%
Bangalore Air	58	3.1%

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Trastuzumab Exports

Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.

Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)

These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Trastuzumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 68 individual customs records matching Zydus Lifesciences Limited exporting Trastuzumab, covering 47 formulations to 8 countries via 15 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 108+ countries, 329+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Trastuzumab

Trastuzumab

Zydus Lifesciences Limited — Trastuzumab Exporter Profile

Zydus Lifesciences Limited — Trastuzumab Export Profile: Buyers & Destinations

Where Does Zydus Lifesciences Limited Export Trastuzumab?

Who Are the Top Buyers of Trastuzumab from Zydus Lifesciences Limited?

What Is India's Total Trastuzumab Export Value and How Much Does Zydus Lifesciences Limited Contribute?

What Is the Average Shipment Value for Zydus Lifesciences Limited's Trastuzumab Exports?

How Does Zydus Lifesciences Limited Compare to Other Indian Trastuzumab Exporters?

What Trastuzumab Formulations Does Zydus Lifesciences Limited Export?

How Does Zydus Lifesciences Limited Compare to Nearest Trastuzumab Exporters?

Which Indian Ports Ship Trastuzumab Exports?

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Trastuzumab Exports

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

About Zydus Lifesciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Trastuzumab Export Data from Zydus Lifesciences Limited

Trastuzumab Stats

Company Overview

Top Products by Zydus Lifesciences Limited

Related Analysis

Need Detailed Export Data?

Data Source